Background and objective Obstructive sleep apnoea (OSA) is a prevalent sleep disorder
associated with increased cardiovascular morbidity and mortality. Whether treatment of OSA …

Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20–
25% in industrialised countries. However, the question of whether it should be routinely …

Obstructive sleep apnea (OSA) is widely prevalent [1]. Central sleep apnea (CSA) is another
common form of sleep-disordered breathing, comorbid with heart failure. Both chronic …

Background: Association between untreated obstructive sleep apnea (OSA) and
cardiovascular disease (CVD) is well known. In this literature review, we aim to review the …

Epidemiological studies provide strong evidence that obstructive sleep apnea (OSA) is
associated with cardiovascular complications such as systemic hypertension, congestive …

Obstructive sleep apnoea | The BMJ Skip to main content Intended for healthcare professionals
Access provided by Google Indexer Subscribe My Account My email alerts BMA member login …

Novel designs for clinical trials on long-term outcomes in the highly prevalent patient group
with OSA addressing the heterogeneity in underlying mechanisms, different phenotypes in …

Abstract The Sleep Apnea cardioVascular Endpoints (SAVE) study is an ongoing
investigator-initiated and conducted, international, multicenter, open, blinded endpoint …

Obstructive sleep apnoea (OSA) is strongly associated with cardiovascular disease (CVD).
However, evidence supporting this association in the Asian population is scarce. Given the …

The obstructive sleep apnoea syndrome (OSAS) is a highly prevalent sleep related
breathing disorder associated with hypopnoea/apnoea, arousals and increased daytime …